MINI FUTURE LONG - BACHEM HOLDING Share Price

Certificat

DE000MG069M9

Real-time Bid/Ask 04:06:15 26/06/2024 pm IST
1.21 EUR / 1.25 EUR +24.24% Intraday chart for MINI FUTURE LONG - BACHEM HOLDING
Current month-18.18%
1 month-45.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
26/24/26 1.26 +27.27%
25/24/25 0.99 -2.94%
24/24/24 1.02 +0.99%
21/24/21 1.01 -1.94%
20/24/20 1.03 +27.16%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 03:50 pm IST

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying BACHEM HOLDING AG
Issuer Morgan Stanley
WKN MG069M
ISINDE000MG069M9
Date issued 13/03/2024
Strike 69.44 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 1.42
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.29
Lowest since issue 0.74
Spread 0.04
Spread %3.20%

Company Profile

Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Sector
-
More about the company

Ratings for Bachem Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Bachem Holding AG

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
6
Last Close Price
79.05 CHF
Average target price
70.8 CHF
Spread / Average Target
-10.44%
Consensus